tiprankstipranks
Advertisement
Advertisement

ESALF Stock Latest News

Eisai Co (ESALF) Q1 Earnings Cheat Sheet
Pre-EarningsEisai Co (ESALF) Q1 Earnings Cheat Sheet
1d ago
Eisai’s E7090 Breast Cancer Trial Reaches Key Milestone, Setting Up Next Investor Catalyst
PremiumCompany Announcements
Eisai’s E7090 Breast Cancer Trial Reaches Key Milestone, Setting Up Next Investor Catalyst
16d ago
ESALF
Eisai Earnings Call Highlights LEQEMBI-Led Growth
PremiumCompany Announcements
Eisai Earnings Call Highlights LEQEMBI-Led Growth
2M ago
Eisai’s E2086 Narcolepsy Trial Adds Quiet Upside Optionality for ESALF Investors
PremiumCompany Announcements
Eisai’s E2086 Narcolepsy Trial Adds Quiet Upside Optionality for ESALF Investors
3M ago
ESALF
Eisai Co (ESALF) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
Eisai Co (ESALF) Q4 Earnings Cheat Sheet
3M ago
Eisai’s E6742 Lupus Trial Advances: What ESALF Investors Need to Know
PremiumCompany AnnouncementsEisai’s E6742 Lupus Trial Advances: What ESALF Investors Need to Know
3M ago
ESALF
Eisai’s Lenvatinib Combo Trial in Liver Cancer Reaches Completion: What Investors Should Watch Next
Premium
Company Announcements
Eisai’s Lenvatinib Combo Trial in Liver Cancer Reaches Completion: What Investors Should Watch Next
3M ago
ESALF
Eisai Advances Early-Stage E2086 Study, Supporting Long-Term Pipeline Value
Premium
Company Announcements
Eisai Advances Early-Stage E2086 Study, Supporting Long-Term Pipeline Value
5M ago
ESALF
Eisai’s E7090 Trial Update: A Targeted Cancer Bet With Growing Investor Relevance
PremiumCompany Announcements
Eisai’s E7090 Trial Update: A Targeted Cancer Bet With Growing Investor Relevance
5M ago
ESALF
ESALF Earnings this Week: How Will it Perform?
PremiumPre-Earnings
ESALF Earnings this Week: How Will it Perform?
6M ago
Eisai’s MORAb-202 Trial: A Promising Step in Cancer Treatment
PremiumCompany Announcements
Eisai’s MORAb-202 Trial: A Promising Step in Cancer Treatment
9M ago
ESALF
Eisai Co.’s Promising Study on E7386: A Game Changer in Cancer Treatment?
PremiumCompany Announcements
Eisai Co.’s Promising Study on E7386: A Game Changer in Cancer Treatment?
9M ago
ESALF
Eisai’s Pediatric Epilepsy Study: A Potential Game-Changer for Investors
PremiumCompany AnnouncementsEisai’s Pediatric Epilepsy Study: A Potential Game-Changer for Investors
9M ago
ESALF
Eisai Co.’s E1018 Study: A Potential Game-Changer in Malaria Treatment
Premium
Company Announcements
Eisai Co.’s E1018 Study: A Potential Game-Changer in Malaria Treatment
9M ago
ESALF
Eisai’s Tasfygo Study: A Closer Look at Safety in Biliary Tract Cancer
Premium
Company Announcements
Eisai’s Tasfygo Study: A Closer Look at Safety in Biliary Tract Cancer
9M ago
ESALF
Eisai Co. Evaluates Fycompa’s Safety in New Clinical Study
PremiumCompany Announcements
Eisai Co. Evaluates Fycompa’s Safety in New Clinical Study
9M ago
ESALF
Eisai Co.’s Tasurgratinib Study: Key Insights for Investors
PremiumCompany Announcements
Eisai Co.’s Tasurgratinib Study: Key Insights for Investors
9M ago
ESALF
Eisai’s Lecanemab Study: A Closer Look at Alzheimer’s Treatment Safety
PremiumCompany Announcements
Eisai’s Lecanemab Study: A Closer Look at Alzheimer’s Treatment Safety
9M ago
ESALF
Eisai’s Tazemetostat Study: A Key Update for Investors
PremiumCompany Announcements
Eisai’s Tazemetostat Study: A Key Update for Investors
9M ago
ESALF
Is ESALF a Buy, Before Earnings?
PremiumPre-EarningsIs ESALF a Buy, Before Earnings?
1y ago
Eisai Co.’s Phase 1 Study of E7389-LF: Potential Game-Changer in Cancer Treatment?
Premium
Company Announcements
Eisai Co.’s Phase 1 Study of E7389-LF: Potential Game-Changer in Cancer Treatment?
1y ago
ESALF
Eisai Co. Advances Cancer Treatment with E7389 Liposomal Study
Premium
Company Announcements
Eisai Co. Advances Cancer Treatment with E7389 Liposomal Study
1y ago
ESALF

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >